LB Pharmaceuticals Inc.
We are developing a novel, patented analogue of amisulpride (AMI) for the US market to treat schizophrenia. AMI is available in Europe but not the US
- Stage Product In Development
- Industry Biotechnology
- Location New York, NY, US
- Currency USD
- Founded September 2015
- Employees 4
- Incorporation Type C-corp
- Website LBPharma.us
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.